Xi'an Deli Biochemical Industry Co., Ltd. participated in the 2025 API China Exhibition held in Chongqing, showcasing the company’s flagship products—Hydroxypropyl Betadex (HPBCD) and Betadex Sulfobutyl Ether Sodium (SBECD)—to global pharmaceutical and chemical industry professionals.
During the exhibition, the Deli Biochemical team engaged in thorough discussions with numerous pharmaceutical manufacturers and trading companies. The team shared key information including:
Visitors expressed strong recognition for the company’s professional technical support and the high stability of product quality.
Participation in the Chongqing API China Exhibition further strengthened Deli Biochemical’s ties with both domestic and international partners. The company will continue to focus on innovation, quality, and service, contributing to the development of the global pharmaceutical excipient industry.